Silver-Russell sendromunda sanal gerçeklik uygulamalarının etkileri: olgu raporu
Öz
Anahtar Kelimeler
Destekleyen Kurum
Proje Numarası
Teşekkür
Kaynakça
- 1. Yalçın Silver HK, Kiyasu W, George J, et al. Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotrophins. Pediatrics. 1953;12:368-376.
- 2. Wakeling EL, Amero SA, Alders M, et al. Epigenotype- phenotype correlations in Silver- Russel syndrome. J Med. Genet. 2010;47:760-768.
- 3. Turner CL, Mackay DM, Callaway JL, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprintedloci. Eur J Hum Genet. 2010;18:648-655.
- 4. Wakeling EL, Brioude F, Lokulo-Sodipe O, et al. Diagnosis and management of Silver–Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017;13:105-124.
- 5. Smeets CC, Renes JS, Van Der Steen M, et al. Metabolic health and long-term safety of growth hormone treatment in Silver-Russell syndrome. J Clin Endocrinol Metab, 2016;102:983-991.
- 6. Azzi S, Abi Habib W, Netchine I. Beckwith–Wiedemann and Russell–Silver Syndromes: From new molecular insights to the comprehension of imprinting regulation Curr Opin Endocrinol Diabetes Obes. 2014;21:30-38.
- 7. Wollmann HA, Kirchner T, Enders H et al. Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 1995;154:958-968.
- 8. Abraham E, Altiok H, Lubicky JP. Musculoskeletal manifestations of Russell-Silver syndrome. J Pediatr Orthop 2004;24:552-564.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Olgu Sunumu
Yazarlar
Aziz Dengız
*
0000-0003-3492-7448
Türkiye
Emre Baskan
0000-0001-7069-0658
Türkiye
Erhan Kızmaz
0000-0003-1973-4146
Türkiye
Yayımlanma Tarihi
29 Nisan 2022
Gönderilme Tarihi
30 Aralık 2020
Kabul Tarihi
22 Şubat 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 9 Sayı: 1